- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/64 - Cyclic peptides containing only normal peptide links
Patent holdings for IPC class C07K 7/64
Total number of patents in this class: 1748
10-year publication summary
|
116
|
109
|
121
|
112
|
118
|
112
|
120
|
109
|
135
|
139
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Polyphor AG | 84 |
48 |
| Entrada Therapeutics, Inc. | 75 |
34 |
| Chugai Seiyaku Kabushiki Kaisha | 1382 |
30 |
| The University of British Columbia | 1539 |
29 |
| Bicyclerd Limited | 149 |
29 |
| Ohio State Innovation Foundation | 2237 |
27 |
| Allergan, Inc. | 2311 |
26 |
| The Regents of the University of California | 20315 |
25 |
| Protagonist Therapeutics, Inc. | 147 |
19 |
| The University of Tokyo | 4252 |
19 |
| Heidelberg Pharma Research GmbH | 79 |
17 |
| Merck Sharp & Dohme LLC | 3735 |
17 |
| Centre National de La Recherche Scientifique | 10716 |
16 |
| University of Southern California | 2125 |
16 |
| Peptidream Inc. | 86 |
15 |
| Technische Universitat Munchen | 700 |
14 |
| Bausch Health Ireland Limited | 806 |
14 |
| Novartis AG | 10595 |
13 |
| Apellis Pharmaceuticals, Inc. | 128 |
13 |
| Farsight Medical Technology (Shanghai) Co., Ltd. | 23 |
13 |
| Other owners | 1314 |